Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis.
ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis. Leukemia. 2019 05; 33(5):1287-1291.
View in:
PubMed
subject areas
Amino Acid Substitution
Disease Progression
Epistasis, Genetic
Gene Expression Regulation
Genetic Predisposition to Disease
Humans
Janus Kinase 2
Mutation
Primary Myelofibrosis
Prognosis
Repressor Proteins
authors with profiles
Zhizhuang Joe Zhao